VBI Vaccines Liabilities 2024

VBI Vaccines Aktienanalyse

What does VBI Vaccines do?

VBI Vaccines Inc is a company focused on the development and commercialization of vaccines. The company was founded in Canada in 2001 and is currently headquartered in Cambridge, Massachusetts, USA. Its business model is based on research, development, and marketing of vaccines for the prevention and treatment of infectious diseases. VBI Vaccines works closely with academic institutions, government agencies, biotech companies, and pharmaceutical companies to advance its products. The company offers a wide range of products, including prophylactic vaccines against infectious diseases such as Hepatitis B, Cytomegalovirus, Japanese encephalitis, and uncontrolled HIV infections. It is also working on the development of therapeutic vaccines against cancer. One of VBI Vaccines' key divisions is the hepatitis B vaccines, with its innovative platform called Sci-B-Vac offering higher protection and longer effectiveness than other available vaccines. VBI Vaccines has also developed a prophylactic platform called LPV™ technology (Lipid Particle Vaccine) which facilitates vaccine production by being easy to manufacture, stable, and transportable. This technology also allows for rapid development of vaccines against new infectious diseases. The company is also involved in the clinical development of therapeutic vaccines against cancer, aiming to mobilize and activate the body's immune system against cancer cells. Successful clinical studies have been conducted for therapy vaccines against glioblastomas (a type of brain tumor) and rhabdomyosarcomas (a rare tumor). Overall, VBI Vaccines has a promising research path for the development of vaccines for the prevention and treatment of infectious diseases and cancer. The company is innovative and relies on technologies that improve vaccine effectiveness and ease their production. VBI Vaccines ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing VBI Vaccines's Liabilities

VBI Vaccines's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating VBI Vaccines's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing VBI Vaccines's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

VBI Vaccines's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in VBI Vaccines’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about VBI Vaccines Stock

What is the level of liabilities of VBI Vaccines this year?

VBI Vaccines has a debt balance of 79.42 M USD this year.

What were the liabilities of VBI Vaccines compared to the previous year?

The liabilities of VBI Vaccines have increased by -12.62% dropped compared to the previous year.

What are the consequences of high debt for investors of VBI Vaccines?

High liabilities can pose a risk for investors of VBI Vaccines, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in VBI Vaccines?

Low liabilities mean that VBI Vaccines has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of VBI Vaccines affect the company?

An increase in liabilities of VBI Vaccines can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of VBI Vaccines affect the company?

A decrease in the liabilities of VBI Vaccines can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of VBI Vaccines?

Some factors that can influence the liabilities of VBI Vaccines include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of VBI Vaccines so important for investors?

The liabilities of VBI Vaccines are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can VBI Vaccines take to modify the liabilities?

To change its liabilities, VBI Vaccines can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does VBI Vaccines pay?

Over the past 12 months, VBI Vaccines paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, VBI Vaccines is expected to pay a dividend of 0 USD.

What is the dividend yield of VBI Vaccines?

The current dividend yield of VBI Vaccines is .

When does VBI Vaccines pay dividends?

VBI Vaccines pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of VBI Vaccines?

VBI Vaccines paid dividends every year for the past 0 years.

What is the dividend of VBI Vaccines?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is VBI Vaccines located?

VBI Vaccines is assigned to the 'Health' sector.

Wann musste ich die Aktien von VBI Vaccines kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of VBI Vaccines from 5/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/27/2024.

When did VBI Vaccines pay the last dividend?

The last dividend was paid out on 5/27/2024.

What was the dividend of VBI Vaccines in the year 2023?

In the year 2023, VBI Vaccines distributed 0 USD as dividends.

In which currency does VBI Vaccines pay out the dividend?

The dividends of VBI Vaccines are distributed in USD.